Bulandos BSN3-1 Duty Drug Study
Bulandos BSN3-1 Duty Drug Study
Bulandos BSN3-1 Duty Drug Study
BSN3-1
DRUG STUDY
GENERIC NAME : ibuprofen
PEDIATRIC PATIENTS
Juvenile arthritis: 30–40 mg/kg/day PO in three to four divided doses; 20
mg/kg/day for milder disease.
Fever (6 mo–12 yr): 5–10 mg/kg PO q 6–8 hr; do not exceed 40 mg/kg/day.
THERAPEUTIC ACTIONS
Ibuprofen exhibits anti-inflammatory, analgesic and antipyretic activities. Its
analgesic effect is independent of anti-inflammatory activity and has both central
and peripheral effects. It potently inhibits the enzyme cyclooxygenase resulting in
the blockage of prostaglandin synthesis. It also prevents formation of thromboxane
A2 by platelet aggregation.
INDICATIONS
Relief of signs and symptoms of rheumatoid arthritis and osteoarthritis
Relief of mild to moderate pain
ROLAN J. BULANDOS JR.
BSN3-1
CONTRAINDICATIONS
Active peptic ulcer; hypersensitivity. Neonates with congenital heart disease,
suspected necrotising enterocolitis and active bleeding (parenteral).
NURSING CONSIDERATIONS
ASSESSMENT
History: Allergy to ibuprofen, salicylates or other NSAIDs; CV dysfunction,
hypertension; peptic ulceration, GI bleeding; impaired hepatic or renal function;
pregnancy; lactation
Physical: Skin color, lesions; T; orientation, reflexes, ophthalmologic evaluation,
audiometric evaluation, peripheral sensation; P, BP, edema; R, adventitious
sounds; liver evaluation, bowel sounds; CBC, clotting times, urinalysis, LFTs, renal
function tests, serum electrolytes, stool guaiac
INTERVENTIONS
BLACK BOX WARNING: Be aware that patient may be at increased risk of CV
event, GI bleeding, monitor accordingly.
Administer drug with food or after meals if GI upset occurs.
Arrange for periodic ophthalmologic examination during long-term therapy.
Discontinue drug if eye changes, symptoms of hepatic impairment, or renal
impairment occur.
WARNING: Institute emergency procedures if overdose occurs: Gastric lavage,
induction of emesis, and supportive therapy.
TEACHING POINTS
Use drug only as suggested; avoid overdose. Take the drug with food or after
meals if GI upset occurs. Do not exceed the prescribed dosage.
Avoid over-the-counter drugs. Many of these drugs contain similar medications,
and serious overdosage can occur.
ROLAN J. BULANDOS JR.
BSN3-1
You may experience these side effects: Nausea, GI upset, dyspepsia (take drug
with food); diarrhea or constipation; drowsiness, dizziness, vertigo, insomnia (use
caution when driving or operating dangerous machinery).
Report sore throat, fever, rash, itching, weight gain, swelling in ankles or fingers,
changes in vision, black or tarry stools.
BRAND NAME:
Suppositories: Abenol (CAN), Acephen
Oral: Aceta, Apacet, Atasol (CAN), Genapap, Genebs, Liquiprin, Mapap,
Panadol, Tapanol, Tempra,Tylenol
Classification: Antipyretic, Analgesic (nonopioid)
Pregnancy Category B
DOSAGES
ADULTS
PO or PR
By suppository, 325–650 mg q 4–6 hr or PO, 1,000 mg tid to qid. Do not exceed
4 g/day.
PEDIATRIC PATIENTS
PO or PR
Doses may be repeated 4–5 times/day; do not exceed five doses in 24 hr; give
PO or by suppository.
Age Dosage (mg)
0–3 mo 40
4–11 mo 80
12–23 mo 120
2–3 yr 160
4–5 yr 240
6–8 yr 320
9–10 yr 400
11 yr 480
THERAPEUTIC ACTIONS
ROLAN J. BULANDOS JR.
BSN3-1
INDICATIONS
ADVERSE EFFECTS
CNS: Headache
CV: Chest pain, dyspnea, myocardial damage when doses of 5–8 g/day are
ingested daily for several weeks or when doses of 4 g/day are ingested for 1 yr
GI: Hepatic toxicity and failure, jaundice
GU: Acute kidney failure, renal tubular necrosis
Hematologic: Methemoglobinemia—cyanosis; hemolytic anemia—hematuria,
anuria; neutropenia, leukopenia, pancytopenia, thrombocytopenia, hypoglycemia
Hypersensitivity: Rash, fever
CONTRAINDICATIONS
NURSING CONSIDERATIONS
ASSESSMENT
History: Allergy to acetaminophen, impaired hepatic function, chronic alcoholism,
pregnancy, lactation
Physical: Skin color, lesions; T; liver evaluation; CBC, LFTs, renal function tests
INTERVENTIONS